News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
337,044 Results
Type
Article (31740)
Company Profile (84)
Press Release (305212)
Multimedia
Podcasts (56)
Webinars (5)
Section
Business (93117)
Career Advice (288)
Deals (12829)
Drug Delivery (75)
Drug Development (48739)
Employer Resources (38)
FDA (6896)
Job Trends (6666)
News (149458)
Policy (12225)
Tag
2025 Best Places to Work (4)
2026 Best Places to Work (8)
2027 BioCapital Standard (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Standard (3)
2027 Genetown Standard (2)
2027 Pharm Country Standard (3)
40 Under 40 (1)
Academia (2118)
Academic (1)
Accelerated approval (41)
ADA (11)
Adcomms (22)
Allergies (57)
Alliances (25310)
ALS (127)
Alzheimer's disease (939)
Antibody-drug conjugate (ADC) (719)
Approvals (7379)
Artificial intelligence (514)
ASCO (340)
Autoimmune disease (268)
Automation (26)
Bankruptcy (99)
Belgium (19)
Best Places to Work (5692)
BIO (45)
Biologics (54)
BIOSECURE Act (15)
Biosimilars (155)
BioSpace Insights (59)
Biotechnology (69)
Bispecific (49)
Bladder cancer (251)
Brain cancer (100)
Breast cancer (981)
Cancer (7920)
Cardiovascular disease (236)
Career advice (284)
Career pathing (11)
CAR-T (368)
CDC (26)
CDMO (92)
Celiac Disease (3)
Cell therapy (793)
Cervical cancer (69)
Clinical research (42652)
Collaboration (1543)
Commercialization (28)
Company closure (7)
Compensation (601)
Complete response letters (48)
COVID-19 (1482)
CRISPR (70)
CRO (5)
C-suite (734)
Cystic fibrosis (56)
Data (6391)
Decentralized trials (3)
Denatured (9)
Depression (61)
Dermatology (67)
Diabetes (227)
Diagnostics (4637)
Digital health (33)
Diversity (8)
Diversity, equity & inclusion (13)
Drug discovery (231)
Drug pricing (74)
Drug shortages (5)
Duchenne muscular dystrophy (68)
Earnings (29976)
Editorial (25)
Employer branding (5)
Employer resources (39)
ESMO (436)
Events (54759)
Executive appointments (567)
Eye disease (12)
FDA (9343)
Fibrodysplasia Ossificans Progressiva (7)
Fragile X (1)
Friedreich's ataxia (13)
Frontotemporal dementia (23)
Funding (1297)
Gene editing (126)
Generative AI (29)
Gene therapy (346)
GLP-1 (381)
Government (2081)
Grass and pollen (1)
Guidances (199)
Healthcare (9589)
Hematology (185)
HIV (56)
Huntington's disease (16)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (17)
Immunology and inflammation (157)
Immuno-oncology (154)
Indications (180)
Infectious disease (1670)
Inflammatory bowel disease (120)
Inflation Reduction Act (6)
Influenza (61)
Intellectual property (164)
Interviews (32)
IPO (6610)
IRA (28)
Job creations (1175)
Job search strategy (255)
JPM (27)
Kidney cancer (31)
Kidney disease (44)
Labor market (33)
Layoffs (253)
Leadership (8)
Legal (2066)
Licensing (58)
Liver cancer (120)
Longevity (25)
Lung cancer (1109)
Lung diease (13)
Lymphoma (519)
Machine learning (43)
Management (12)
Manufacturing (549)
Marketing (18)
MASH (110)
Medical affairs (2)
Medical device (4148)
Medtech (4218)
Mergers & acquisitions (6896)
Metabolic disorders (584)
Middle East (1)
mRNA (196)
Multiple sclerosis (86)
Multispecific (5)
NASH (5)
Netherlands (41)
Neurodegenerative disease (211)
Neuropsychiatric disorders (32)
Neuroscience (1677)
NextGen: Class of 2026 (2748)
Non-profit (2758)
Now hiring (22)
Obesity (231)
Opinion (149)
Ovarian cancer (300)
Pain (121)
Pancreatic cancer (458)
Parkinson's disease (162)
Partnered (21)
Patents (359)
Patient advocacy (4)
Patient recruitment (542)
Patient selection (70)
Peanut (15)
People (28024)
Peptides (16)
Pharmaceutical (16)
Pharmacy benefit managers (10)
Phase 1 (15287)
Phase 2 (18671)
Phase 3 (13063)
Pipeline (7443)
Policy (161)
Postmarket research (1338)
Preclinical (6599)
Press Release (49)
Prostate cancer (414)
Psychedelics (33)
Radioligand (3)
Radiopharmaceuticals (393)
Rare diseases (552)
Real estate (2117)
Recruiting (19)
Regenerative medicine (15)
Regulatory (11597)
Reports (25)
Research institute (2252)
Resumes & cover letters (21)
Rett syndrome (7)
RNA editing (16)
RSV (31)
Saudi Arabia (1)
Schizophrenia (76)
Series A (192)
Series B (123)
Service/supplier (1)
Sickle cell disease (67)
Special edition (7)
Spinal muscular atrophy (57)
Sponsored (16)
Startups (1865)
State (1)
Stem cells (6)
Stomach cancer (24)
Substance use disorders (14)
Supply chain (48)
Switzerland (6)
Tariffs (28)
Tax incentives (1)
The Weekly (47)
Vaccines (675)
Venture capital (77)
Weight loss (128)
Wet AMD (1)
Women's health (79)
Women in leadership (1)
Worklife (5)
Date
Today (113)
Last 7 days (418)
Last 30 days (1889)
Last 365 days (15220)
2026 (13694)
2025 (15280)
2024 (17917)
2023 (20320)
2022 (26389)
2021 (27608)
2020 (24967)
2019 (20763)
2018 (15475)
2017 (15631)
2016 (15205)
2015 (17551)
2014 (13253)
2013 (10769)
2012 (10995)
2011 (11435)
2010 (10589)
Location
Africa (329)
Alabama (77)
Alaska (4)
Arizona (156)
Arkansas (7)
Asia (22771)
Australia (4363)
California (7985)
Canada (2041)
China (1305)
Colorado (387)
Connecticut (368)
Delaware (328)
Europe (50698)
Florida (1270)
Georgia (210)
Hawaii (1)
Idaho (22)
Illinois (695)
India (62)
Indiana (396)
Iowa (18)
Japan (391)
Kansas (42)
Kentucky (33)
Louisiana (18)
Maine (17)
Maryland (918)
Massachusetts (5470)
Michigan (94)
Minnesota (332)
Mississippi (1)
Missouri (98)
Montana (19)
Nebraska (9)
Nevada (51)
New Hampshire (49)
New Jersey (2450)
New Mexico (14)
New York (2490)
North Carolina (685)
North Dakota (4)
Northern California (4283)
Ohio (186)
Oklahoma (10)
Oregon (13)
Pennsylvania (1378)
Puerto Rico (14)
Rhode Island (27)
South America (410)
South Carolina (27)
Southern California (3149)
Tennessee (111)
Texas (1778)
United States (28479)
Utah (192)
Vermont (2)
Virginia (152)
Washington D.C. (52)
Washington State (832)
West Virginia (3)
Wisconsin (112)
Wyoming (1)
337,044 Results for "netherlands cancer institute nci".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rakovina Therapeutics to Present ATR Inhibitor Data in PTEN-Deficient Prostate Cancer at the 38th EORTC-NCI-AACR Symposium
November 16, 2026
·
5 min read
Press Releases
Trethera Selected as a 2026–2027 National Cancer Institute Investor Showcase Company
October 29, 2026
·
5 min read
Press Releases
MTTI Awarded $3.17 Million NCI Grant to Advance ¹⁷⁷Lu-EBRGD Development for Non-Small Cell Lung Cancer
September 22, 2026
·
6 min read
Press Releases
Kovina Therapeutics Awarded $2.3 Million NCI Grant to Advance First-in-Class HPV Cancer Therapy Directly Targeting E6
September 24, 2026
·
2 min read
Press Releases
Immuneering to Highlight Atebimetinib’s Broad Potential for Combinations in Pancreatic and Anaplastic Thyroid Cancers at the 2026 EORTC-NCI-AACR Symposium
November 4, 2026
·
6 min read
Press Releases
Adcendo ApS to Present ADCE-D01 Phase 1 Clinical Data in Advanced Soft Tissue Sarcoma in Late-Breaking Oral Presentation at 2026 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
November 10, 2026
·
2 min read
Press Releases
Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 27, 2026
·
3 min read
Press Releases
Frontier Medicines to Present Preclinical Data for FMC-242, a Novel Covalent Allosteric PI3Kα-RAS Breaker, at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
November 4, 2026
·
5 min read
Press Releases
Envisagenics Awarded $2M+ NCI SBIR Grant to Expand AI-Driven RNA Splicing Analysis Capabilities Across Oncology Portfolio
October 13, 2026
·
4 min read
Press Releases
Remix Therapeutics Selected for Late-Breaking Oral Presentation at the 38th EORTC-NCI-AACR Symposium
October 28, 2026
·
3 min read
1 of 33,705
Next